Does Castor Oil Make Your Eyelashes Grow?

What Castor Oil Is, and What People Use It For on Lashes

Castor oil is a pale yellow vegetable oil cold-pressed from the seeds of Ricinus communis. It is classified as a cosmetic ingredient under FDA regulation. A 2025 Cosmetic Ingredient Review re-review confirmed castor oil's safety at cosmetic concentrations. People apply it to the lash line hoping to grow longer, thicker lashes.

Ricinoleic acid makes up roughly 85–90% of castor oil's fatty-acid profile. Smaller amounts of oleic, linoleic, palmitic, and stearic acids round out the rest. Ricinoleic acid is the molecule that carries the proposed mechanism: a 2012 study showed it activates prostaglandin EP3 receptors in gut and uterine tissue.

Cold-pressed castor oil is the standard cosmetic form. Solvent-extracted versions exist but are less common in beauty products. "Jamaican black castor oil" is roasted before pressing, giving it a darker color and smokier scent, but its fatty-acid composition is essentially the same. Neither version is the same as bimatoprost-containing prescription lash products. Those work through an entirely different receptor pathway and require a prescription. Castor oil remains a cosmetic ingredient, not a drug.

What Castor Oil Really Does on the Lash Line

The central question is whether castor oil acts locally on lash and lid tissue, systemically through absorption, or both. For lash-line application, the answer is almost entirely local, and even that local action is about emollient conditioning, not follicle stimulation.

Local action on the lash line and lid margin

Applied to the lash shaft, castor oil functions as an occlusive emollient. It coats the hair surface, reduces moisture loss, and may decrease mechanical breakage, making existing lashes appear fuller. That is a cosmetic effect, not hair growth. Separately, there is real evidence for castor oil's benefit at the lid margin: a 2021 RCT found periocular castor oil improved blepharitis symptoms, and a supporting review confirmed its role in meibomian gland dysfunction and dry eye. That lid-margin benefit is real, but it is not lash growth. The ricinoleic acid → EP3 mechanism operates in gut and uterine tissue, not lash follicles. Eyelash follicles respond to prostaglandin F2α and FP-receptor agonists, a different receptor pathway entirely.

Whether it reaches the bloodstream, and what that means

At cosmetic lash-line doses, systemic absorption of castor oil is negligible. A few drops on the lash margin do not produce meaningful circulating levels of ricinoleic acid. The claim that ricinoleic acid is "anti-inflammatory" (sometimes used to market castor oil for lash growth) is based on gut and animal data. It does not translate to a systemic anti-inflammatory effect from topical lash-line application. There is no pharmacologic pathway by which this application route drives follicle biology.

What the Castor Oil Research Does and Doesn't Show

Evidence grades reflect the human and preclinical record for castor oil specifically — not for prostaglandin analogs as a class. The five tiers are: Strong, Moderate, Limited, Animal-only, and Anecdotal.

Castor oil grows eyelashes and promotes lash growth: Anecdotal

There are no clinical RCTs specifically testing castor oil for eyelash growth. None. The same ricinoleic acid → EP3 mechanism, documented in 2012, operates in gut and uterine tissue, not in lash follicles. The prostaglandin-eyelash growth link is established for FP-receptor agonists like bimatoprost and latanoprost. A 2002 paper laid the groundwork for the prostaglandin–lash growth link; 2010 and 2012 papers confirmed it for bimatoprost specifically. EP3 agonism is a different pathway. Castor oil's effect on lashes is most consistent with occlusive conditioning of existing hairs, a cosmetic effect, not anagen prolongation. The evidence base for castor oil growing eyelashes is absent.

Castor oil conditions lashes and may make them appear fuller: Limited

As an occlusive emollient, castor oil coats the lash shaft and reduces moisture loss. This is consistent with the behavior of any heavy plant oil applied to hair. The conditioning effect (improved shine, reduced brittleness, apparent fullness) is what cosmetic users most likely experience. This is not the same as growing new lashes or extending the anagen phase. The effect is real but modest, and it is shared by other occlusive oils.

Castor oil benefits blepharitis and meibomian gland function: Moderate

A 2021 RCT of periocular castor oil in blepharitis showed meaningful improvement in lid-margin symptoms. A supporting review confirmed therapeutic potential for meibomian gland dysfunction and dry eye. This is the strongest evidence castor oil has in the periocular space. Importantly, it is evidence for lid-margin and gland function, not for lash growth. Someone searching "castor oil for eyelashes" because their lids feel irritated may actually be dealing with a lid-margin issue, not a lash issue.

Castor oil compared to bimatoprost (Latisse): Anecdotal vs. bimatoprost's Moderate-to-Strong

Bimatoprost has a multicenter RCT behind it. A 2012 multicenter trial demonstrated significant eyelash growth versus vehicle, supporting FDA approval for eyelash hypotrichosis. A 2010 paper characterized the mechanism: FP-receptor agonism prolongs anagen and increases follicle size. Castor oil has no comparable evidence. That said, bimatoprost carries a documented side-effect profile, periorbital fat atrophy and iris pigmentation are established concerns, with recent prospective data reinforcing those risks. The contrast here is mechanistic and regulatory: an Rx FP-receptor agonist with clinical-trial evidence is not equivalent to a cosmetic emollient oil.

How Castor Oil Is Used on Lashes (and the Eye-Safety Caveats)

Cosmetic use of castor oil on the lash line is practice, not a clinical protocol — no dosing standard exists, and application methods vary widely in safety depending on proximity to the eye.

Where to apply

Apply to the lash line using a clean spoolie brush or microbrush. Never apply directly from the bottle. Precision matters near the eye. Accidental contact with the cornea can cause irritation, as with any oil applied near the eye; avoid it. Do not apply if there is active eye irritation, conjunctivitis, or a recent eye procedure. Remove contact lenses before application to avoid lens contamination. For lid-margin or blepharitis use (the indication with actual clinical evidence), application follows the 2021 trial protocol under clinical guidance, not a DIY lash routine.

How often + patch-test first

Patch-test on the inner forearm for 24–48 hours before any lash-line application. Allergic contact dermatitis from castor-oil-containing products is documented and not rare enough to skip this step. Popular cosmetic protocols suggest nightly application, but no clinical trial has defined an optimal frequency for lash conditioning. Do not apply castor oil to or near children's eyes. Case reports of lipoid pneumonia from oil aspiration in pediatric populations are documented, and a 2020 review confirms the risk is class-based across viscous oils, not castor-oil-specific, which makes pediatric use a documented avoid.

Reader Fit and the Honest Contraindications

Castor oil for lash conditioning may suit someone with intact lashes who wants a low-cost emollient to reduce shaft dryness and brittleness. It is also a reasonable option for someone with mild lid-margin dryness who wants a simple occlusive product. Someone seeking actual lash regrowth (longer, denser lashes where follicles are underperforming) is reaching for the wrong tool.

• Have active eye irritation, conjunctivitis, or have had recent eye surgery or a procedure.
• Have a known castor or ricin sensitivity, or a history of contact dermatitis from plant oils.
• Wear contact lenses during application (lens contamination risk).
• Are applying it to a child: case reports of lipoid pneumonia from oil aspiration in pediatric populations are documented, and a 2020 review confirms the risk is class-based across viscous oils, not castor-oil-specific.
• Are expecting it to grow lashes. The evidence base for that effect is absent, and an Rx FP-receptor agonist is the validated path if clinically indicated.

Lash loss following chemotherapy, alopecia areata, or thyroid disease is a clinical picture, not a cosmetic one. The same applies to lash thinning associated with chronic blepharitis or recent eye procedures. These situations call for dermatology, ophthalmology, or primary-care evaluation. If any of this applies, the right next step is a clinician, not a different topical oil.

Castor Oil's Side Effects, FDA Status, and the Bimatoprost Comparison

FDA status. Castor oil is classified as a cosmetic ingredient under FDA cosmetics law, as a 2025 Cosmetic Ingredient Review re-review confirmed. It is not FDA-approved as a drug for any indication, including eyelash growth. Marketing it for lash growth crosses into drug-claim territory. As of May 2026, the only FDA-approved prescription treatment for eyelash hypotrichosis is bimatoprost (Latisse).

Common side effects. Case reports describe allergic contact dermatitis as the most documented adverse event, including reactions from castor-oil-containing dressings. Accidental eye contact has been associated with corneal irritation. Occasional folliculitis at the lid margin has also been reported. Castor oil is not universally inert.

Drug interactions and Rx-vs-OTC framing. FDA-approved eyelash growth products work via prostaglandin analog FP-receptor agonism, a mechanism with multicenter RCT evidence behind it. A 2012 multicenter trial and a 2010 comprehensive review establish that evidence base. Castor oil's ricinoleic acid operates on EP3 receptors, a different pathway with no equivalent eyelash-growth evidence. For someone using bimatoprost concurrently, there is no documented pharmacologic interaction with castor oil. They are not redundant products. Bimatoprost is the validated growth agent; castor oil is, at most, a conditioner.

Pregnancy and breastfeeding. Topical lash-line castor oil at cosmetic doses involves negligible systemic absorption, so the pregnancy concern is not specific to this route. Oral castor oil has a separate history as a laxative and uterine stimulant (the same ricinoleic acid → EP3 pathway documented in 2012) and is avoided in pregnancy. That is the oral route, not the lash-line route. No controlled human safety data exist for topical lash-line castor oil application during pregnancy; standard caution applies.

Biomarkers Worth Running Before Chasing Any Lash-Growth Product

If the reason for searching "castor oil eyelashes" is actual lash thinning or hair loss, the underlying biology determines whether any topical is even the right intervention. Thyroid dysfunction, low iron stores, and vitamin D insufficiency are measurable upstream drivers of lash and hair loss. A topical sits downstream of that question.

• TSH: Thyroid-stimulating hormone, both hypo- and hyperthyroidism are major confounders for hair and lash loss. Without ruling thyroid dysfunction out, any topical experiment is uninterpretable.
• Free T3 and Free T4: These confirm the active thyroid hormone picture beyond TSH alone. They are particularly relevant when TSH sits in the upper-normal range alongside persistent hair-loss symptoms.
• Ferritin: Iron stores, low ferritin is a well-characterized driver of telogen effluvium and hair shedding, including lashes, well before frank anemia appears.
• Vitamin D: Low vitamin D status is associated with hair-cycle dysregulation in observational data. It is not a deterministic cause, but it is a reasonable baseline check.

When Lash Loss Deserves a Clinician, Not a Cosmetic Oil

Lash loss accompanying chemotherapy, alopecia areata, thyroid disease, recent eye procedures, or chronic blepharitis is a clinical picture. Dermatology, ophthalmology, or primary care is the appropriate next step, not a topical oil. The cosmetic case for castor oil is conditioning intact lashes; the clinical case for lash loss is workup and diagnosis.

Measuring the underlying biology (thyroid, iron, vitamin D) before applying any new topical is the foundation of Superpower's approach to preventive health.

Alternatives to Castor Oil for Lash Concerns

The alternatives to castor oil span a wide evidence range: from a prescription prostaglandin analog with clinical-trial data for lash hypotrichosis to systemic-cause correction (thyroid, iron, vitamin D) that addresses lash loss at its source.

• Castor oil (cosmetic conditioning). Evidence for lash growth: Anecdotal. Evidence as an emollient conditioner: Limited. Typical US cost: $5–$15 per bottle. Best suited for cosmetic conditioning of intact lashes, not for actual lash regrowth.
• Bimatoprost (Latisse). Rx FP-receptor agonist. Evidence for eyelash hypotrichosis: Moderate-to-Strong, via a 2012 multicenter RCT, with mechanism characterized in a 2010 paper and reviewed in a 2010 comprehensive review. Typical US cost: high, often not insurance-covered. Best suited for clinically diagnosed lash hypotrichosis under ophthalmologic supervision, with the documented side-effect profile (periorbital fat atrophy and iris pigmentation) factored in.
• Underlying-biology workup. Evidence for treating a documented upstream driver, iron repletion, thyroid management, vitamin D repletion, on hair and lash outcomes is Moderate where the deficiency is confirmed. Cost: bloodwork is typically insurance-covered; lifestyle interventions are free. Best suited for anyone whose lash thinning reflects a measurable systemic issue.
• Other cosmetic lash conditioners. Emollients like squalane and conditioning lash serums without prostaglandin analogs carry similar Limited-grade evidence to castor oil for conditioning. Typical cost: moderate. Best suited for readers seeking conditioning without castor oil, including those with contact sensitivity documented in 2025 case reports.

For someone whose lash thinning is driven by hypothyroidism or iron deficiency, no topical (castor oil or bimatoprost) substitutes for treating the upstream issue. Bimatoprost belongs in this comparison because it is the actual clinical-trial-validated lash-growth product. Castor oil is not its equivalent. The right tool depends entirely on what the underlying biology shows.